Yes, Augmentin (amoxicillin-clavulanate) can be used for cellulitis and is an appropriate first-line treatment option.
Augmentin is effective for cellulitis and should be considered as a first-line treatment, particularly when β-lactamase-producing organisms or mixed infections are suspected. The combination provides coverage against both streptococci (the most common cause of nonpurulent cellulitis) and staphylococci, including β-lactamase-producing strains 1.
Evidence Supporting Use
FDA-Approved Activity
Augmentin demonstrates activity against key cellulitis pathogens 1:
- Staphylococcus aureus (including β-lactamase-producing strains, but NOT methicillin-resistant strains)
- Streptococcus pyogenes (Group A strep)
- The clavulanic acid component protects amoxicillin from β-lactamase degradation, extending coverage to resistant organisms
Clinical Outcomes Data
Recent retrospective analysis (2019) of 59 hospitalized patients with erysipelas or bacterial cellulitis found that amoxicillin-clavulanate was associated with the shortest hospital stay (7.0 ± 2.9 days average) compared to cephalosporins or clindamycin 2. This combination therapy was also least often associated with the need for additional antibacterial agents.
A separate 2019 study of 630 cases demonstrated that adherence to guidelines recommending amoxicillin-clavulanate resulted in significantly better outcomes: only 6.3% poor outcomes versus 12.7% in non-adherent cases (p=0.007) 3. Guideline adherence was the only modifiable protective factor against poor outcomes.
Clinical Context and Limitations
Important Caveats
MRSA coverage: Augmentin does NOT cover methicillin-resistant S. aureus 1. In areas with high community MRSA prevalence or when purulent cellulitis suggests MRSA, alternative agents are needed.
Diagnostic uncertainty: The 2014 IDSA guidelines note that in nonpurulent cellulitis, pathogen isolation occurs in <20% of cases 4. This means you're treating empirically 80% of the time, making broad-spectrum coverage reasonable.
Streptococcal cellulitis: For confirmed streptococcal cellulitis alone, amoxicillin without clavulanate is sufficient 1. However, since you rarely have microbiologic confirmation at treatment initiation, the broader coverage of Augmentin is pragmatic.
Practical Prescribing
Dosing considerations: Standard adult dosing is 875 mg/125 mg twice daily. Higher doses (875 mg/125 mg formulation) provide enhanced coverage against resistant organisms 5.
Common side effects: Gastrointestinal symptoms (nausea 9%, diarrhea 9%) and rash (3-4%) are most frequent 6, 7. These are generally mild and self-limited.
Duration: While specific cellulitis duration studies are limited, typical courses range 5-10 days based on clinical response. The IDSA guidelines acknowledge that definitive duration data for soft tissue infections remain a research priority 4.
Bottom Line Algorithm
Use Augmentin for cellulitis when:
- Nonpurulent cellulitis without obvious abscess
- No known MRSA risk factors (recent MRSA infection, high local prevalence, injection drug use)
- Mixed infection suspected (trauma, bite wounds, diabetic foot)
- β-lactamase producers possible (prior antibiotic exposure)
Switch to MRSA-active agents (e.g., doxycycline, trimethoprim-sulfamethoxazole, clindamycin) if:
- Purulent drainage present
- High MRSA risk
- Failure to improve after 48-72 hours on Augmentin